Position in PFE
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$670,026
-$440,032 QoQ
Shares Held
27,825
-29.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,558
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CX Institutional holds $115,444,232 across 15 Drug Manufacturers - General names. PFE ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,493 | $42,571,372 | |
| 2 | ABBV |
AbbVie Inc.
|
78,286 | $19,699,889 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
263,596 | $15,188,401 | |
| 4 | MRK |
Merck & Co., Inc.
|
95,317 | $12,248,234 | |
| 5 | AMGN |
Amgen Inc
|
25,985 | $9,409,688 | |
| 6 | JNJ |
Johnson & Johnson
|
30,364 | $7,711,545 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,297 | $7,365,242 | |
| 8 | PFE |
Pfizer Inc
This page
|
27,825 | $670,026 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $670,026 | 27,825 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $1,110,058 | 39,532 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $928,545 | 37,291 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $914,044 | 35,873 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,140,055 | 47,032 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $791,494 | 31,235 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,336,846 | 50,390 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,337,230 | 46,207 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $717,826 | 25,655 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $1,389,109 | 50,058 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $3,162,811 | 109,858 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $3,457,342 | 104,231 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,744,867 | 47,570 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $2,224,008 | 54,510 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,803,340 | 54,710 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,953,971 | 44,652 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $5,284,262 | 100,787 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $4,482,764 | 86,590 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $6,309,374 | 106,848 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,482,554 | 34,470 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,594,663 | 66,258 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,289,373 | 63,190 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $3,565,711 | 96,868 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $4,041,106 | 110,112 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $876,262 | 26,797 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $887,186 | 27,181 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||